<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:01a020bc-05d6-7326-aa3c-c583ed6e9c2b,g:a7a26c87-2037-4424-9631-c46bc6606ffb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"/>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/CondensedBalanceSheets" xlink:type="simple" xlink:href="abos-20260930.xsd#CondensedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/CondensedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_01a020bc-066a-708c-aad6-226c03b1fd78" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_01a020bc-066a-71d9-9bdf-1ac0cc916626" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_01a020bc-066a-708c-aad6-226c03b1fd78" xlink:to="loc_us-gaap_LiabilitiesCurrent_01a020bc-066a-71d9-9bdf-1ac0cc916626" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_01a020bc-066a-701a-b057-8b85631ecbd4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_01a020bc-066a-708c-aad6-226c03b1fd78" xlink:to="loc_us-gaap_LongTermDebt_01a020bc-066a-701a-b057-8b85631ecbd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_01a020bc-066a-765d-9356-5e55b75d8e77" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_01a020bc-066a-77a2-a675-09c0fa4f6343" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_01a020bc-066a-765d-9356-5e55b75d8e77" xlink:to="loc_us-gaap_AssetsCurrent_01a020bc-066a-77a2-a675-09c0fa4f6343" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_01a020bc-066a-7a25-b28b-b4a0438854c5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_01a020bc-066a-765d-9356-5e55b75d8e77" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_01a020bc-066a-7a25-b28b-b4a0438854c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_01a020bc-066a-7d82-be3a-039999a123a2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_01a020bc-066a-765d-9356-5e55b75d8e77" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_01a020bc-066a-7d82-be3a-039999a123a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_01a020bc-066a-702e-a1ad-d02e37e0d945" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_01a020bc-066a-71ba-b539-7262b352cff4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_01a020bc-066a-702e-a1ad-d02e37e0d945" xlink:to="loc_us-gaap_Liabilities_01a020bc-066a-71ba-b539-7262b352cff4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_01a020bc-066a-7ab8-aa66-55eb49866eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_01a020bc-066a-702e-a1ad-d02e37e0d945" xlink:to="loc_us-gaap_CommitmentsAndContingencies_01a020bc-066a-7ab8-aa66-55eb49866eb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_01a020bc-066a-7fbf-81de-167c041194b5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_01a020bc-066a-702e-a1ad-d02e37e0d945" xlink:to="loc_us-gaap_StockholdersEquity_01a020bc-066a-7fbf-81de-167c041194b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_01a020bc-066a-70de-b312-4ed36d2df1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_01a020bc-066a-7521-b9f6-b7cf02c35527" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_01a020bc-066a-70de-b312-4ed36d2df1eb" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_01a020bc-066a-7521-b9f6-b7cf02c35527" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_01a020bc-066a-79cd-9646-97a378c1bf63" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_01a020bc-066a-70de-b312-4ed36d2df1eb" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_01a020bc-066a-79cd-9646-97a378c1bf63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_01a020bc-066a-7efe-b5e1-fcbfb4ee54d0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_01a020bc-066a-70de-b312-4ed36d2df1eb" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_01a020bc-066a-7efe-b5e1-fcbfb4ee54d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_01a020bc-066a-781c-bd92-0b018fd8c110" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_AccruedClinicalTrialExpensesCurrent_01a020bc-066a-791d-b3c0-5b0d0007462e" xlink:href="abos-20260930.xsd#abos_AccruedClinicalTrialExpensesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_01a020bc-066a-781c-bd92-0b018fd8c110" xlink:to="loc_abos_AccruedClinicalTrialExpensesCurrent_01a020bc-066a-791d-b3c0-5b0d0007462e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_01a020bc-066a-7c3b-bd73-45fde2fde35b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_01a020bc-066a-781c-bd92-0b018fd8c110" xlink:to="loc_us-gaap_AccountsPayableCurrent_01a020bc-066a-7c3b-bd73-45fde2fde35b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_01a020bc-066a-7dc8-9559-a7e4558f8b64" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_01a020bc-066a-781c-bd92-0b018fd8c110" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_01a020bc-066a-7dc8-9559-a7e4558f8b64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_01a020bc-066a-79d1-8978-7728482aae9b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_01a020bc-066a-781c-bd92-0b018fd8c110" xlink:to="loc_us-gaap_ShortTermBorrowings_01a020bc-066a-79d1-8978-7728482aae9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_01a020bc-066a-7f4c-b516-c223b7e419af" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_01a020bc-066a-76ce-87bd-076d9d0c6ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_01a020bc-066a-7f4c-b516-c223b7e419af" xlink:to="loc_us-gaap_PreferredStockValue_01a020bc-066a-76ce-87bd-076d9d0c6ed5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_01a020bc-066a-760a-9ed9-2bd7c29bce6d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_01a020bc-066a-7f4c-b516-c223b7e419af" xlink:to="loc_us-gaap_CommonStockValue_01a020bc-066a-760a-9ed9-2bd7c29bce6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_01a020bc-066a-774c-a725-6fe0fe70f51f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_01a020bc-066a-7f4c-b516-c223b7e419af" xlink:to="loc_us-gaap_AdditionalPaidInCapital_01a020bc-066a-774c-a725-6fe0fe70f51f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_01a020bc-066a-7dbf-97ac-6a3d6e0af75f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_01a020bc-066a-7f4c-b516-c223b7e419af" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_01a020bc-066a-7dbf-97ac-6a3d6e0af75f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_01a020bc-066a-79a3-b6d3-b37d06f4a28f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_01a020bc-066a-7f4c-b516-c223b7e419af" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_01a020bc-066a-79a3-b6d3-b37d06f4a28f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/CondensedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="abos-20260930.xsd#CondensedStatementsofOperationsandComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/CondensedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_01a020bc-066a-736f-8751-c797ed147e52" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_01a020bc-066a-7979-b382-e46e19af4fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_01a020bc-066a-736f-8751-c797ed147e52" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_01a020bc-066a-7979-b382-e46e19af4fa3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_01a020bc-066a-7cca-9ae4-c21871cec378" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_01a020bc-066a-736f-8751-c797ed147e52" xlink:to="loc_us-gaap_NetIncomeLoss_01a020bc-066a-7cca-9ae4-c21871cec378" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_01a020bc-066a-743c-a15a-0fb58f1d053a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_01a020bc-066a-7d04-9c94-7a1ee3fcc3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_01a020bc-066a-743c-a15a-0fb58f1d053a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_01a020bc-066a-7d04-9c94-7a1ee3fcc3ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_01a020bc-066a-7b85-a539-64233454b500" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_01a020bc-066a-743c-a15a-0fb58f1d053a" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_01a020bc-066a-7b85-a539-64233454b500" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_01a020bc-066a-7f2a-86c3-ff4905401ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_01a020bc-066a-786b-a354-cc2fd72eb3bc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_01a020bc-066a-7f2a-86c3-ff4905401ad5" xlink:to="loc_us-gaap_InvestmentIncomeInterest_01a020bc-066a-786b-a354-cc2fd72eb3bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_01a020bc-066a-71b6-8015-3b43f37c6744" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_01a020bc-066a-7f2a-86c3-ff4905401ad5" xlink:to="loc_us-gaap_InterestExpenseNonoperating_01a020bc-066a-71b6-8015-3b43f37c6744" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_01a020bc-066a-73db-8ed9-7fb8fc6e1498" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_01a020bc-066a-7f2a-86c3-ff4905401ad5" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_01a020bc-066a-73db-8ed9-7fb8fc6e1498" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_01a020bc-066a-7ee7-9464-91e248da8356" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_01a020bc-066a-7f2a-86c3-ff4905401ad5" xlink:to="loc_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_01a020bc-066a-7ee7-9464-91e248da8356" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_01a020bc-066a-7836-916b-06211add2cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_01a020bc-066a-787a-8cbf-3badfd448b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_01a020bc-066a-7836-916b-06211add2cb0" xlink:to="loc_us-gaap_OperatingIncomeLoss_01a020bc-066a-787a-8cbf-3badfd448b7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_01a020bc-066a-7631-8b32-4289c20d6276" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_01a020bc-066a-7836-916b-06211add2cb0" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_01a020bc-066a-7631-8b32-4289c20d6276" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_01a020bc-066a-7d0d-ab60-5a03139c03c7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_01a020bc-066a-734a-973e-0816ded98ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_01a020bc-066a-7d0d-ab60-5a03139c03c7" xlink:to="loc_us-gaap_OperatingExpenses_01a020bc-066a-734a-973e-0816ded98ebd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/CondensedStatementsofCashFlows" xlink:type="simple" xlink:href="abos-20260930.xsd#CondensedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/CondensedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_01a020bc-066b-748a-b44c-4d3ec7d7f538" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01a020bc-066b-7e70-8d4b-c6eb2fb5aefd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_01a020bc-066b-748a-b44c-4d3ec7d7f538" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01a020bc-066b-7e70-8d4b-c6eb2fb5aefd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a020bc-066b-72f5-aa8b-5c2d20667e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_01a020bc-066b-748a-b44c-4d3ec7d7f538" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a020bc-066b-72f5-aa8b-5c2d20667e9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_01a020bc-066b-71be-b10d-d7f8ef91225a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_01a020bc-066b-748a-b44c-4d3ec7d7f538" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_01a020bc-066b-71be-b10d-d7f8ef91225a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a020bc-066b-7c50-a961-35a0334fe1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_01a020bc-066b-7e31-a1c0-dc70ae9742f8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a020bc-066b-7c50-a961-35a0334fe1e3" xlink:to="loc_us-gaap_NetIncomeLoss_01a020bc-066b-7e31-a1c0-dc70ae9742f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_01a020bc-066b-7236-a064-9c7849aa8e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a020bc-066b-7c50-a961-35a0334fe1e3" xlink:to="loc_us-gaap_Depreciation_01a020bc-066b-7236-a064-9c7849aa8e5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_01a020bc-066b-7647-a04a-0670fd6fbf07" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a020bc-066b-7c50-a961-35a0334fe1e3" xlink:to="loc_us-gaap_ShareBasedCompensation_01a020bc-066b-7647-a04a-0670fd6fbf07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_01a020bc-066b-7a98-8554-fb1f6ecff67e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a020bc-066b-7c50-a961-35a0334fe1e3" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_01a020bc-066b-7a98-8554-fb1f6ecff67e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_01a020bc-066b-725e-b1b5-6bcc2717e2f4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a020bc-066b-7c50-a961-35a0334fe1e3" xlink:to="loc_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_01a020bc-066b-725e-b1b5-6bcc2717e2f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_01a020bc-066b-75ac-b325-b76dbe458f18" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a020bc-066b-7c50-a961-35a0334fe1e3" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_01a020bc-066b-75ac-b325-b76dbe458f18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_01a020bc-066b-7b0c-8aaf-5e1f0e2c0592" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a020bc-066b-7c50-a961-35a0334fe1e3" xlink:to="loc_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_01a020bc-066b-7b0c-8aaf-5e1f0e2c0592" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_OtherNoncashExpenseInterest_01a020bc-066b-70ea-a863-d5227affa28f" xlink:href="abos-20260930.xsd#abos_OtherNoncashExpenseInterest"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a020bc-066b-7c50-a961-35a0334fe1e3" xlink:to="loc_abos_OtherNoncashExpenseInterest_01a020bc-066b-70ea-a863-d5227affa28f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_01a020bc-066b-7852-afb2-c55e8d9cd975" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a020bc-066b-7c50-a961-35a0334fe1e3" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_01a020bc-066b-7852-afb2-c55e8d9cd975" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_01a020bc-066b-773e-ae50-fe291c1cd24e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a020bc-066b-7c50-a961-35a0334fe1e3" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_01a020bc-066b-773e-ae50-fe291c1cd24e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_01a020bc-066b-7ba8-85c7-705bc19bf8c1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a020bc-066b-7c50-a961-35a0334fe1e3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_01a020bc-066b-7ba8-85c7-705bc19bf8c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_IncreaseDecreaseInAccruedClinicalTrialExpenses_01a020bc-066b-7f55-9c25-85dac4f646cb" xlink:href="abos-20260930.xsd#abos_IncreaseDecreaseInAccruedClinicalTrialExpenses"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a020bc-066b-7c50-a961-35a0334fe1e3" xlink:to="loc_abos_IncreaseDecreaseInAccruedClinicalTrialExpenses_01a020bc-066b-7f55-9c25-85dac4f646cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_01a020bc-066b-7b95-8c68-14dece37bab9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a020bc-066b-7c50-a961-35a0334fe1e3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_01a020bc-066b-7b95-8c68-14dece37bab9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_01a020bc-066a-7f6a-9aa0-831a71e158ec" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_01a020bc-066a-770a-8dea-4d3919cb598c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_01a020bc-066a-7f6a-9aa0-831a71e158ec" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_01a020bc-066a-770a-8dea-4d3919cb598c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_01a020bc-066a-7005-a822-f1fabc8190d7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_01a020bc-066a-7f6a-9aa0-831a71e158ec" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_01a020bc-066a-7005-a822-f1fabc8190d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_01a020bc-066b-7833-a255-cd591621913e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_01a020bc-066a-7f6a-9aa0-831a71e158ec" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_01a020bc-066b-7833-a255-cd591621913e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01a020bc-066b-75bb-98cd-05f42072364c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_01a020bc-066b-7606-8d19-cdd409574644" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01a020bc-066b-75bb-98cd-05f42072364c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_01a020bc-066b-7606-8d19-cdd409574644" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_01a020bc-066b-7ccc-ba55-1a16b85cdc3b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01a020bc-066b-75bb-98cd-05f42072364c" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_01a020bc-066b-7ccc-ba55-1a16b85cdc3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_01a020bc-066b-7f92-b59e-71fdaf26f5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01a020bc-066b-75bb-98cd-05f42072364c" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_01a020bc-066b-7f92-b59e-71fdaf26f5a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_01a110f9-07f1-7f69-9f59-3103c6df9118" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01a020bc-066b-75bb-98cd-05f42072364c" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_01a110f9-07f1-7f69-9f59-3103c6df9118" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="abos-20260930.xsd#BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_01a020bc-066b-7cb7-a511-417f1b360701" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_01a020bc-066b-7d1d-8fda-f38e508b6f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_01a020bc-066b-7cb7-a511-417f1b360701" xlink:to="loc_us-gaap_RestrictedCash_01a020bc-066b-7d1d-8fda-f38e508b6f5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_01a020bc-066b-78ff-a11a-f4ffe94aaa82" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_01a020bc-066b-7cb7-a511-417f1b360701" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_01a020bc-066b-78ff-a11a-f4ffe94aaa82" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/MARKETABLESECURITIESScheduleofMarketableSecuritiesDetails" xlink:type="simple" xlink:href="abos-20260930.xsd#MARKETABLESECURITIESScheduleofMarketableSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/MARKETABLESECURITIESScheduleofMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_01a020bc-066b-7da0-a6c8-bcdc05b429bb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_01a020bc-066b-7d9d-a061-a9fdc21746c9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_01a020bc-066b-7da0-a6c8-bcdc05b429bb" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_01a020bc-066b-7d9d-a061-a9fdc21746c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent_01a020bc-066b-7621-94f2-334f1cb7fb57" xlink:href="abos-20260930.xsd#abos_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_01a020bc-066b-7da0-a6c8-bcdc05b429bb" xlink:to="loc_abos_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent_01a020bc-066b-7621-94f2-334f1cb7fb57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxCurrent_01a020bc-066b-787c-8db1-0372b12b0506" xlink:href="abos-20260930.xsd#abos_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxCurrent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_01a020bc-066b-7da0-a6c8-bcdc05b429bb" xlink:to="loc_abos_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxCurrent_01a020bc-066b-787c-8db1-0372b12b0506" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/MARKETABLESECURITIESScheduleofUnrealizedLossonInvestmentsDetails" xlink:type="simple" xlink:href="abos-20260930.xsd#MARKETABLESECURITIESScheduleofUnrealizedLossonInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/MARKETABLESECURITIESScheduleofUnrealizedLossonInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_01a020bc-066b-7157-b428-41b125de4772" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_01a020bc-066b-7409-8da1-a0e106b91f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_01a020bc-066b-7157-b428-41b125de4772" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_01a020bc-066b-7409-8da1-a0e106b91f0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_01a020bc-066b-735d-9a32-716bb6caef45" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_01a020bc-066b-7157-b428-41b125de4772" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_01a020bc-066b-735d-9a32-716bb6caef45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_01a020bc-066b-72ef-aa66-b99d21696664" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_01a020bc-066b-7f2c-88fe-cf5b7f5d5559" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_01a020bc-066b-72ef-aa66-b99d21696664" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_01a020bc-066b-7f2c-88fe-cf5b7f5d5559" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_01a020bc-066b-7d65-91b2-ed6d68a6185a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_01a020bc-066b-72ef-aa66-b99d21696664" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_01a020bc-066b-7d65-91b2-ed6d68a6185a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="abos-20260930.xsd#FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_01a020bc-066b-733b-9621-5b749d9483c8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_01a020bc-066b-79ac-b7c5-1d5dd48f9582" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_01a020bc-066b-733b-9621-5b749d9483c8" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_01a020bc-066b-79ac-b7c5-1d5dd48f9582" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_01a020bc-066b-7296-92ca-9289ac8d95fb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_01a020bc-066b-733b-9621-5b749d9483c8" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_01a020bc-066b-7296-92ca-9289ac8d95fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_01a020bc-066b-7502-b06f-8d66c9d6bc18" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_01a020bc-066b-7a3e-b42a-00428186669d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_01a020bc-066b-7502-b06f-8d66c9d6bc18" xlink:to="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_01a020bc-066b-7a3e-b42a-00428186669d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="abos-20260930.xsd#SUPPLEMENTALFINANCIALINFORMATIONScheduleofPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneous_01a020bc-0701-7f19-a98b-00ef78578c86" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsMiscellaneous"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_01a020bc-0701-7668-853b-986a32ebee34" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsMiscellaneous_01a020bc-0701-7f19-a98b-00ef78578c86" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_01a020bc-0701-7668-853b-986a32ebee34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_01a020bc-0701-785a-92b1-ba3a43f0b922" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsMiscellaneous_01a020bc-0701-7f19-a98b-00ef78578c86" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_01a020bc-0701-785a-92b1-ba3a43f0b922" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_01a020bc-0701-789e-8636-dbd2561ab26c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentServiceAgreementsCurrent_01a020bc-0701-73c7-ad9b-9772670443fc" xlink:href="abos-20260930.xsd#abos_ResearchAndDevelopmentServiceAgreementsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_01a020bc-0701-789e-8636-dbd2561ab26c" xlink:to="loc_abos_ResearchAndDevelopmentServiceAgreementsCurrent_01a020bc-0701-73c7-ad9b-9772670443fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_01a020bc-0701-7c91-969c-f045f94537f6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_01a020bc-0701-789e-8636-dbd2561ab26c" xlink:to="loc_us-gaap_OtherReceivables_01a020bc-0701-7c91-969c-f045f94537f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_01a020bc-0701-7c43-8d70-5a9eeea879a1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_01a020bc-0701-789e-8636-dbd2561ab26c" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_01a020bc-0701-7c43-8d70-5a9eeea879a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_01a020bc-0701-7f7f-9173-3c26fd9d7447" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidInsurance"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_01a020bc-0701-789e-8636-dbd2561ab26c" xlink:to="loc_us-gaap_PrepaidInsurance_01a020bc-0701-7f7f-9173-3c26fd9d7447" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_DuesAndSubscriptions_01a020bc-0701-7907-bf62-167a679f7fb8" xlink:href="abos-20260930.xsd#abos_DuesAndSubscriptions"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_01a020bc-0701-789e-8636-dbd2561ab26c" xlink:to="loc_abos_DuesAndSubscriptions_01a020bc-0701-7907-bf62-167a679f7fb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssets_01a020bc-0701-733b-b77a-bf9bb5c661f2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentServiceAgreements_01a020bc-0701-7eaf-b02f-d630896de013" xlink:href="abos-20260930.xsd#abos_ResearchAndDevelopmentServiceAgreements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_01a020bc-0701-733b-b77a-bf9bb5c661f2" xlink:to="loc_abos_ResearchAndDevelopmentServiceAgreements_01a020bc-0701-7eaf-b02f-d630896de013" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneous_01a020bc-0701-76db-b387-2a2701843bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsMiscellaneous"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_01a020bc-0701-733b-b77a-bf9bb5c661f2" xlink:to="loc_us-gaap_OtherAssetsMiscellaneous_01a020bc-0701-76db-b387-2a2701843bc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_01a020bc-0701-789f-a0db-45f6788b9af2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherReceivables"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_01a020bc-0701-733b-b77a-bf9bb5c661f2" xlink:to="loc_us-gaap_OtherReceivables_01a020bc-0701-789f-a0db-45f6788b9af2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_01a020bc-0701-725b-ae5d-38233d326e79" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_01a020bc-0701-733b-b77a-bf9bb5c661f2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_01a020bc-0701-725b-ae5d-38233d326e79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_01a020bc-0701-759c-9786-aa892279c6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidInsurance"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_01a020bc-0701-733b-b77a-bf9bb5c661f2" xlink:to="loc_us-gaap_PrepaidInsurance_01a020bc-0701-759c-9786-aa892279c6c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_DuesAndSubscriptions_01a020bc-0701-758f-ad46-d316d1cf8313" xlink:href="abos-20260930.xsd#abos_DuesAndSubscriptions"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_01a020bc-0701-733b-b77a-bf9bb5c661f2" xlink:to="loc_abos_DuesAndSubscriptions_01a020bc-0701-758f-ad46-d316d1cf8313" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_01a020bc-0701-7cf6-9455-97560e565493" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_01a020bc-0701-733b-b77a-bf9bb5c661f2" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_01a020bc-0701-7cf6-9455-97560e565493" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_01a020bc-0701-7623-8a39-e1f8a2c90615" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_01a020bc-0701-7464-8864-d5a130c78450" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_01a020bc-0701-7623-8a39-e1f8a2c90615" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_01a020bc-0701-7464-8864-d5a130c78450" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_01a020bc-0701-7741-bf58-e2df3cd33cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_01a020bc-0701-7623-8a39-e1f8a2c90615" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_01a020bc-0701-7741-bf58-e2df3cd33cbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentServiceAgreementsNoncurrent_01a020bc-0701-737b-b695-4394a1adba7d" xlink:href="abos-20260930.xsd#abos_ResearchAndDevelopmentServiceAgreementsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_01a020bc-0701-7623-8a39-e1f8a2c90615" xlink:to="loc_abos_ResearchAndDevelopmentServiceAgreementsNoncurrent_01a020bc-0701-737b-b695-4394a1adba7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_01a020bc-0701-739e-b478-3664f883cff5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_01a020bc-0701-7623-8a39-e1f8a2c90615" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_01a020bc-0701-739e-b478-3664f883cff5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentServiceAgreements_01a020bc-0701-7e2a-8c3d-1c8d9f76e776" xlink:href="abos-20260930.xsd#abos_ResearchAndDevelopmentServiceAgreements"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentServiceAgreementsCurrent_01a020bc-0701-778b-b606-67f869d44b3b" xlink:href="abos-20260930.xsd#abos_ResearchAndDevelopmentServiceAgreementsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_abos_ResearchAndDevelopmentServiceAgreements_01a020bc-0701-7e2a-8c3d-1c8d9f76e776" xlink:to="loc_abos_ResearchAndDevelopmentServiceAgreementsCurrent_01a020bc-0701-778b-b606-67f869d44b3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentServiceAgreementsNoncurrent_01a020bc-0701-7212-ac91-d2fc60259ffd" xlink:href="abos-20260930.xsd#abos_ResearchAndDevelopmentServiceAgreementsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_abos_ResearchAndDevelopmentServiceAgreements_01a020bc-0701-7e2a-8c3d-1c8d9f76e776" xlink:to="loc_abos_ResearchAndDevelopmentServiceAgreementsNoncurrent_01a020bc-0701-7212-ac91-d2fc60259ffd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofPrepaidExpensesandOtherCurrentAssetsDetails_1" xlink:type="simple" xlink:href="abos-20260930.xsd#SUPPLEMENTALFINANCIALINFORMATIONScheduleofPrepaidExpensesandOtherCurrentAssetsDetails_1"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofPrepaidExpensesandOtherCurrentAssetsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssets_01a020bc-0701-7a20-9bc0-2d83472681a7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_01a020bc-0701-7fc9-a306-ac81b4c77852" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_01a020bc-0701-7a20-9bc0-2d83472681a7" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_01a020bc-0701-7fc9-a306-ac81b4c77852" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_01a020bc-0701-7922-b296-6b59955438ff" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_01a020bc-0701-7a20-9bc0-2d83472681a7" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_01a020bc-0701-7922-b296-6b59955438ff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="abos-20260930.xsd#SUPPLEMENTALFINANCIALINFORMATIONScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_01a020bc-0701-7e7e-86dd-889f5bab7343" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentLiability_01a020bc-0701-7c1e-b022-d1edee1142a6" xlink:href="abos-20260930.xsd#abos_ResearchAndDevelopmentLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_01a020bc-0701-7e7e-86dd-889f5bab7343" xlink:to="loc_abos_ResearchAndDevelopmentLiability_01a020bc-0701-7c1e-b022-d1edee1142a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_01a020bc-0701-71a9-8c4a-0d5a54f58384" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_01a020bc-0701-7e7e-86dd-889f5bab7343" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_01a020bc-0701-71a9-8c4a-0d5a54f58384" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_01a020bc-0701-7da8-b6b3-bd109c84c44a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_01a020bc-0701-7e7e-86dd-889f5bab7343" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_01a020bc-0701-7da8-b6b3-bd109c84c44a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_01a020bc-0701-7638-b36e-78a21a561a23" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_01a020bc-0701-7e7e-86dd-889f5bab7343" xlink:to="loc_us-gaap_OperatingLeaseLiability_01a020bc-0701-7638-b36e-78a21a561a23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilities_01a020bc-0701-7b4d-90bd-199e194d1d00" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherSundryLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_01a020bc-0701-7e7e-86dd-889f5bab7343" xlink:to="loc_us-gaap_OtherSundryLiabilities_01a020bc-0701-7b4d-90bd-199e194d1d00" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/DEBTScheduleofOutstandingDebtDetails" xlink:type="simple" xlink:href="abos-20260930.xsd#DEBTScheduleofOutstandingDebtDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/DEBTScheduleofOutstandingDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_01a020bc-0701-751d-96ba-28c76908dc8d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_01a020bc-0701-7bf4-add1-cdf09724f2c3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_01a020bc-0701-751d-96ba-28c76908dc8d" xlink:to="loc_us-gaap_ShortTermBorrowings_01a020bc-0701-7bf4-add1-cdf09724f2c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_01a020bc-0701-7c53-a4f7-3a916e33cc00" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_01a020bc-0701-751d-96ba-28c76908dc8d" xlink:to="loc_us-gaap_LongTermDebt_01a020bc-0701-7c53-a4f7-3a916e33cc00" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/DEBTScheduleofOutstandingDebtDetails_1" xlink:type="simple" xlink:href="abos-20260930.xsd#DEBTScheduleofOutstandingDebtDetails_1"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/DEBTScheduleofOutstandingDebtDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_01a020bc-0701-785e-baa8-e6af0e4d3019" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_01a020bc-0701-7bf5-b069-f0ca38333c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_01a020bc-0701-785e-baa8-e6af0e4d3019" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_01a020bc-0701-7bf5-b069-f0ca38333c7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_01a020bc-0701-78f1-bca1-382d0dd562b4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_01a020bc-0701-785e-baa8-e6af0e4d3019" xlink:to="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_01a020bc-0701-78f1-bca1-382d0dd562b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_01a020bc-0701-7dff-9349-7df2b7350479" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_01a020bc-0701-785e-baa8-e6af0e4d3019" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_01a020bc-0701-7dff-9349-7df2b7350479" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/DEBTScheduleofInterestExpenseDebtDetails" xlink:type="simple" xlink:href="abos-20260930.xsd#DEBTScheduleofInterestExpenseDebtDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/DEBTScheduleofInterestExpenseDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_01a020bc-0701-7021-92a4-cece941f5b89" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestExpenseDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_01a020bc-0701-7f02-8d6c-2a108a246064" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_01a020bc-0701-7021-92a4-cece941f5b89" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_01a020bc-0701-7f02-8d6c-2a108a246064" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_01a020bc-0701-70ca-9ef0-c8b3a86a651d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_01a020bc-0701-7021-92a4-cece941f5b89" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_01a020bc-0701-70ca-9ef0-c8b3a86a651d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/DEBTScheduleofAggregatePrincipalPaymentsDetails" xlink:type="simple" xlink:href="abos-20260930.xsd#DEBTScheduleofAggregatePrincipalPaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/DEBTScheduleofAggregatePrincipalPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_01a020bc-0701-7109-95b0-f3062c927dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_01a020bc-0701-75f0-8114-8810b4dd8d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_01a020bc-0701-7109-95b0-f3062c927dc2" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_01a020bc-0701-75f0-8114-8810b4dd8d0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_01a020bc-0701-7717-9a21-6f7262c7cde6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_01a020bc-0701-7109-95b0-f3062c927dc2" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_01a020bc-0701-7717-9a21-6f7262c7cde6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/SEGMENTREPORTINGScheduleofFinancialInformationaboutCompanysOperatingSegmentDetails" xlink:type="simple" xlink:href="abos-20260930.xsd#SEGMENTREPORTINGScheduleofFinancialInformationaboutCompanysOperatingSegmentDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/SEGMENTREPORTINGScheduleofFinancialInformationaboutCompanysOperatingSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_01a020bc-0702-7145-8c5b-477d388c1d02" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_01a020bc-0702-7d0e-87d3-83d9946cd417" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_01a020bc-0702-7145-8c5b-477d388c1d02" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_01a020bc-0702-7d0e-87d3-83d9946cd417" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_01a020bc-0702-791e-8253-b3234562f567" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_01a020bc-0702-7145-8c5b-477d388c1d02" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_01a020bc-0702-791e-8253-b3234562f567" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentExternalCosts_01a020bc-0702-7c8c-9b19-f54bf3c73bf0" xlink:href="abos-20260930.xsd#abos_ResearchAndDevelopmentExternalCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_01a020bc-0702-7145-8c5b-477d388c1d02" xlink:to="loc_abos_ResearchAndDevelopmentExternalCosts_01a020bc-0702-7c8c-9b19-f54bf3c73bf0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_01a020bc-0702-7bfa-a4de-1469b1459e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_01a020bc-0702-7145-8c5b-477d388c1d02" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_01a020bc-0702-7bfa-a4de-1469b1459e5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentInternallyManagedCosts_01a020bc-0702-7c01-b823-01469990563c" xlink:href="abos-20260930.xsd#abos_ResearchAndDevelopmentInternallyManagedCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_01a020bc-0702-7145-8c5b-477d388c1d02" xlink:to="loc_abos_ResearchAndDevelopmentInternallyManagedCosts_01a020bc-0702-7c01-b823-01469990563c" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
